“…[25][26][27][28] Assess patients for changes in cardiopulmonary status, including a sudden decrease in SpO 2 , dyspnea, shortness of breath, tachypnea, changes in breath or heart sounds, or tachycardia that occur during or within 6 hours after the transfusion is completed. Changes in the patient's clinical status during the transfusion should be compared to baseline assessment data.…”